Wirkung und Nebenwirkung der Cyproteronacetatbehandlung
- 作者W. Braendle; H. Boess; M. Breckwoldt; Ch. Leven; G. Bettendorf
- 卷第216卷
- 期第4期
- 印刷ISSN0932-0067
- 电子ISSN1432-0711
- 文件大小589.62KB
- 发表时间1974
- DOI10.1007/bf01347138
- 页码335-345
Seizure promotion by D1agonists does not correlate with other dopaminergic propertiesM. S. Starr; B. S. Starr · 1993
Glutamate-dopamine interactions in the production of pilocarpine motor seizures in the mouseM. S. Starr; B. S. Starr · 1993
Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonistM. S. Starr; B. S. Starr · 1995
Putative Neurotoxicity of SKF 38393 and Other D1 Dopaminergic Drugs Investigated in Rat StriatumL. Isaac; R. Mills; L. J. Fowler; B. S. Starr; M. S. Starr · 1992
Motor actions of eliprodil in the normal and monoamine-depleted mouse: A role in the treatment of Parkinson's disease?S. Brooks; S. Kaur; B. S. Starr; M. S. Starr · 1996
Potentiation of dopamine-dependent locomotion by clonidine in reserpine-treated mice is restricted to D2agonistsM. S. Starr; B. S. Starr · 1994
The Status of Cytomegalovirus VaccineS. E. Starr; H. M. Friedman; S. A. Plotkin · 1991
Strong metal support interaction on Co/niobia model catalystsF. M. T. Mendes; A. Uhl; D. E. Starr; S. Guimond; M. Schmal; H. Kuhlenbeck; S. K. Shaikhutdinov; H.-J. Freund · 2006